|

Spanish Series of Patients Treated With the Radionuclide Lutetium177

RECRUITINGSponsored by Sociedad Española de Medicina Nuclear e Imagen Molecular
Actively Recruiting
SponsorSociedad Española de Medicina Nuclear e Imagen Molecular
Started2021-05-10
Est. completion2034-12-31
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04949282

Summary

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Written informed consent must be obtained prior to any data collection.
* Patients must be diagnosed with unresectable or metastatic, progressive, somatostatin receptor positive tumour
* Aged ≥18 years.

Exclusion Criteria:

* None

Conditions19

CancerDigestive System DiseasesDigestive System NeoplasmsEndocrine Gland NeoplasmsEndocrine System DiseasesGastrointestinal DiseaseGastrointestinal NeoplasmsIntestinal DiseasesIntestinal NeoplasmsNeoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.